All Type of News
SK Chemicals and Sanofi Pasteur sign license agreement of ‘cell culture technology’The SK Chemicals’ technological level has once been recognized by the world as the company exported its vaccine manufacturing technology to a global pharmaceutical company.
SK ...
|
LegoChem Bio’s Phase II clinical trial of ‘Super Antibody’ designated for accelerated approval by FDA
LegoChem Biosciences(LegoChem Bio) officially announced that Delpazloid(LCB01-0371), a Phase II clinical trial pipeline, was designated as a medicine for the Fast Track process by the U.S. Food and Drug Administration...
High chance for the next deliberative committee to be held after KPA’s regular general meeting
The people are paying attention to when they will resume the discussion of adjusting the emergency household medicine list, which has been suspended for more than 2 months.
The anticipation is followed because the Ko...
MOHW, “MFDS has been very cooperative in legislating acts for cutting-edge biologics and regenerative medicine”
As understanding the purpose of promoting industries of cutting-edge biologics and regenerative medicines, the Ministry of Health and Welfare(MOHW) announced to cooperate with legislating regulations related to them.
...
Spread of words about prosecution investigating rebates either February and March
The pharmaceutical industry has started to concern about rebate inspections once again. This is because the concern is connected to a personnel reshuffle at the Seoul Western District(SWD) Prosecutors’ Office which ha...
Celltrion Group to decide final location to construct Factory 3 in another countryCelltrion Chairman Jung-Jin Seo released its next-gen pipelines and global market strategies that were planned to carry out by 2030 at the ‘2018 Celltrion Healthcare Internation...
|
“It is inadequate for government to take expenses for return of mis/unused medicines”
In response to the Korea Pharmaceutical Association’s(KPA) opinion to obligate return of mis/unused medicines, the Ministry of Health and Welfare(MOHW) answered that it was inadequate.
The MOHW revealed the ‘Stance t...
Conflicts between medical association and government over entirely switching uninsured medical services to insured
Over a discussion about the whole change of uninsured medical services to insured, the government and the Korea Medical Association(KMA) have had conflicts.
The Ministry of Health and Welfare(MOHW) expressed disappoi...
Hanmi CEO Sae-Chang Kwon, “We applied FDA approval for Rolontis and Olita’s Phase III clinical trial”Hanmi Pharm(CEO Sae-Chang Kwon) has set the ‘Hanmi Innovative Management to Become Pharmaceutical Power’ ’as their new year’s resolution.
“During my more than 20-year career at...
|
MFDS revises drug approval/assessment guidelines to meet the ICH standards
In order to support pharmaceutical companies’ development of medicines and advance regulations in the drug field, the Ministry of Food and Drug Safety(MFDS) will revise the approval/assessment guidelines at the intern...
